Agilent Technologies Inc
A107.580USD
+0.120+0.11%
Handelsschluss 04/30, 16:00（ET）Kurse um 15 Minuten verzögert
30.69BMarktkapitalisierung
24.37KGV TTM
mehr Informationen über Agilent Technologies Inc Unternehmen
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Unternehmensinformationen
Unternehmens-codeA
Name des UnternehmensAgilent Technologies Inc
IPO-datumNov 18, 1999
Gegründet am1999
CEOMr. Padraig McDonnell
Anzahl der mitarbeiter17900
WertpapierartOrdinary Share
GeschäftsjahresendeNov 18
Addresse5301 Stevens Creek Blvd
StadtSANTA CLARA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl95051
Telefon14083458886
Websitehttps://www.agilent.com/
Unternehmens-codeA
IPO-datumNov 18, 1999
Gegründet am1999
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Chief Accounting Officer, Vice President, Corporate Controllership
Chief Accounting Officer, Vice President, Corporate Controllership
39.42K
-4.62%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Mr. Padraig McDonnell
Mr. Padraig McDonnell
Chief Executive Officer, Director
Chief Executive Officer, Director
12.19K
-2.23%
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.73K
+32.49%
Dr. Simon May
Dr. Simon May
Senior Vice President, President, Diagnostics and Genomics
Senior Vice President, President, Diagnostics and Genomics
7.69K
+81.51%
Dr. Mikael G. Dolsten, M.D., Ph.D.
Dr. Mikael G. Dolsten, M.D., Ph.D.
Independent Director
Independent Director
7.54K
+31.77%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Chief Accounting Officer, Vice President, Corporate Controllership
Chief Accounting Officer, Vice President, Corporate Controllership
39.42K
-4.62%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Non-instrumentation and other
1.06B
62.82%
Instrumentation
625.00M
37.18%
Nach RegionUSD
Name
Umsatz
Anteil
United States
669.00M
39.80%
Asia Pacific
549.00M
32.66%
Europe
463.00M
27.54%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Non-instrumentation and other
1.06B
62.82%
Instrumentation
625.00M
37.18%
Aktionäre
Update-Zeit: 12 hours ago
Update-Zeit: 12 hours ago
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
11.59%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.46%
MFS Investment Management
4.03%
Wellington Management Company, LLP
3.26%
Other
71.28%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
11.59%
BlackRock Institutional Trust Company, N.A.
5.38%
State Street Global Advisors (US)
4.46%
MFS Investment Management
4.03%
Wellington Management Company, LLP
3.26%
Other
71.28%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
46.43%
Investment Advisor
33.51%
Hedge Fund
3.31%
Pension Fund
1.88%
Research Firm
1.78%
Insurance Company
1.41%
Bank and Trust
1.39%
Sovereign Wealth Fund
1.29%
Family Office
0.44%
Other
8.55%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2117
259.41M
90.98%
-10.92M
2024Q4
2144
261.66M
91.77%
-9.44M
2024Q3
2092
261.54M
91.00%
-12.94M
2024Q2
2065
263.61M
90.36%
-18.36M
2024Q1
2066
270.62M
92.35%
-9.44M
2023Q4
2084
269.59M
92.01%
-3.30M
2023Q3
2017
262.63M
89.76%
-13.56M
2023Q2
2002
268.16M
90.78%
-20.64M
2023Q1
1985
271.86M
91.93%
-13.10M
2022Q4
1944
268.33M
90.62%
-17.98M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.04M
11.59%
-403.17K
-1.21%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
15.33M
5.38%
-244.77K
-1.57%
Dec 31, 2024
State Street Global Advisors (US)
12.71M
4.46%
-105.89K
-0.83%
Dec 31, 2024
MFS Investment Management
11.49M
4.03%
-3.02M
-20.80%
Dec 31, 2024
Wellington Management Company, LLP
9.31M
3.26%
+59.78K
+0.65%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
8.23M
2.89%
-6.73K
-0.08%
Dec 31, 2024
Geode Capital Management, L.L.C.
7.00M
2.46%
+53.99K
+0.78%
Dec 31, 2024
Pictet Asset Management Ltd.
5.21M
1.83%
+47.49K
+0.92%
Dec 31, 2024
Generation Investment Management LLP
4.16M
1.46%
+1.13M
+37.08%
Dec 31, 2024
State Farm Insurance Companies
3.83M
1.34%
--
--
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
ProShares Nanotechnology ETF
4.59%
Global X Genomics & Biotechnology ETF
4.5%
Parnassus Value Select ETF
4.12%
First Trust Water ETF
3.69%
Honeytree US Equity ETF
3.54%
VanEck Morningstar Wide Moat Growth ETF
3.42%
Global X Telemedicine & Digital Health ETF
3.31%
Madison Covered Call ETF
2.95%
Argent Mid Cap ETF
2.29%
VanEck Morningstar Wide Moat ETF
2.2%
Mehr Anzeigen
ProShares Nanotechnology ETF
Anteil4.59%
Global X Genomics & Biotechnology ETF
Anteil4.5%
Parnassus Value Select ETF
Anteil4.12%
First Trust Water ETF
Anteil3.69%
Honeytree US Equity ETF
Anteil3.54%
VanEck Morningstar Wide Moat Growth ETF
Anteil3.42%
Global X Telemedicine & Digital Health ETF
Anteil3.31%
Madison Covered Call ETF
Anteil2.95%
Argent Mid Cap ETF
Anteil2.29%
VanEck Morningstar Wide Moat ETF
Anteil2.2%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.25B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
May 18, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option
Jul 03, 2023
Jul 26, 2023
Jun 30, 2023
Feb 22, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023
Apr 04, 2023
Apr 26, 2023
Apr 03, 2023
Nov 16, 2022
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 25, 2023
Dec 30, 2022
Sep 21, 2022
A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 26, 2022
Oct 03, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten